Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

Jay Jiguang Zhu, Petya Demireva, Andrew A. Kanner, Susan Pannullo, Maximilian Mehdorn, Nicholas Avgeropoulos, Andrea Salmaggi, Antonio Silvani, Samuel Goldlust, Carlos David, Alexandra Benouaich-Amiel, Zvi Ram on behalf of the EF-14 Trial Investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences